1. Home
  2. JAZZ vs WTS Comparison

JAZZ vs WTS Comparison

Compare JAZZ & WTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • WTS
  • Stock Information
  • Founded
  • JAZZ 2003
  • WTS 1874
  • Country
  • JAZZ Ireland
  • WTS United States
  • Employees
  • JAZZ N/A
  • WTS N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • WTS Metal Fabrications
  • Sector
  • JAZZ Health Care
  • WTS Industrials
  • Exchange
  • JAZZ Nasdaq
  • WTS Nasdaq
  • Market Cap
  • JAZZ 8.1B
  • WTS 7.1B
  • IPO Year
  • JAZZ 2007
  • WTS 1986
  • Fundamental
  • Price
  • JAZZ $136.01
  • WTS $214.83
  • Analyst Decision
  • JAZZ Strong Buy
  • WTS Hold
  • Analyst Count
  • JAZZ 14
  • WTS 5
  • Target Price
  • JAZZ $177.50
  • WTS $220.00
  • AVG Volume (30 Days)
  • JAZZ 688.4K
  • WTS 211.5K
  • Earning Date
  • JAZZ 02-25-2025
  • WTS 02-10-2025
  • Dividend Yield
  • JAZZ N/A
  • WTS 0.80%
  • EPS Growth
  • JAZZ 458.10
  • WTS 11.13
  • EPS
  • JAZZ 7.04
  • WTS 8.69
  • Revenue
  • JAZZ $3,992,712,000.00
  • WTS $2,252,200,000.00
  • Revenue This Year
  • JAZZ $7.53
  • WTS $1.15
  • Revenue Next Year
  • JAZZ $6.94
  • WTS $3.51
  • P/E Ratio
  • JAZZ $19.42
  • WTS $24.81
  • Revenue Growth
  • JAZZ 5.23
  • WTS 9.53
  • 52 Week Low
  • JAZZ $99.06
  • WTS $175.37
  • 52 Week High
  • JAZZ $138.27
  • WTS $232.60
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 68.46
  • WTS 53.50
  • Support Level
  • JAZZ $134.56
  • WTS $213.72
  • Resistance Level
  • JAZZ $138.27
  • WTS $220.46
  • Average True Range (ATR)
  • JAZZ 3.56
  • WTS 5.82
  • MACD
  • JAZZ 1.17
  • WTS 0.57
  • Stochastic Oscillator
  • JAZZ 88.20
  • WTS 47.35

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About WTS Watts Water Technologies Inc.

Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, and heating systems; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. The company generates the majority of its revenue from markets in the Americas and in Europe, the Middle East, and Africa.

Share on Social Networks: